Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation

Chiara Pedone; Francesco Grigioni; Giuseppe Boriani; Carla Lofiego; Pier Luigi Vassallo; Luciano Potena; Fabio Coccolo; Gaia Magnani; Mauro Biffi; Cristian Martignani; Lorenzo Frabetti; Romano Zannoli; Carlo Magelli; Angelo Branzi

doi:10.1016/j.amjcard.2003.10.024

Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation

Am J Cardiol. 2004 Feb 1;93(3):371-3. doi: 10.1016/j.amjcard.2003.10.024.

Authors

Chiara Pedone¹, Francesco Grigioni, Giuseppe Boriani, Carla Lofiego, Pier Luigi Vassallo, Luciano Potena, Fabio Coccolo, Gaia Magnani, Mauro Biffi, Cristian Martignani, Lorenzo Frabetti, Romano Zannoli, Carlo Magelli, Angelo Branzi

Affiliation

¹ Institute of Cardiology, University Hospital S. Orsola Malpighi, Bologna, Italy.

PMID: 14759396
DOI: 10.1016/j.amjcard.2003.10.024

Abstract

This study analyzed the relations and time-related changes in eligibility for cardiac resynchronization therapy and prophylactic defibrillator implantation in 161 potential candidates for heart transplantation. Although up to 62% of patients who fulfilled the severity criteria for heart transplantation were eligible for either device, this percentage increased as clinical/instrumental parameters of heart failure severity worsened.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Cardiac Pacing, Artificial*
Defibrillators, Implantable*
Electric Countershock*
Eligibility Determination
Female
Heart Failure / therapy*
Heart Transplantation*
Humans
Male
Middle Aged
Severity of Illness Index
Time Factors
Treatment Outcome